Amvuttra 71336-1003
Generic: Vutrisiran
Product NDC
71336-1003- Manufacturer
- Alnylam Pharmaceuticals, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 13, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA215515
Need to source Amvuttra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vutrisiran Sodium | 25 mg/.5mL |
Drug Class
Decreased RNA Integrity [PE]Increased Protein Breakdown [PE]RNA
Packaging Options(1)
1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS